Hester Biosciences buys ICAR IVRI technologies for classical swine fever, sheep pox vaccines

"Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100 per cent protection," Hester Biosciences said.

Published On 2021-04-09 07:37 GMT   |   Update On 2021-04-10 04:33 GMT

New Delhi: Animal healthcare firm Hester Biosciences on Thursday said it has acquired technologies from the Indian Council of Agricultural Research – Indian Veterinary Research Institute (ICAR – IVRI) for production and commercialisation of vaccines for classical swine fever and sheep pox.Classical swine fever vaccine and sheep pox vaccine have been developed within the country by...

Login or Register to read the full article

New Delhi: Animal healthcare firm Hester Biosciences on Thursday said it has acquired technologies from the Indian Council of Agricultural Research – Indian Veterinary Research Institute (ICAR – IVRI) for production and commercialisation of vaccines for classical swine fever and sheep pox.

Classical swine fever vaccine and sheep pox vaccine have been developed within the country by using locally isolated strains, Hester Biosciences said in a filing to BSE.

The technologies were developed by ICAR-IVRI and the commercialisation of the technologies was facilitated by Agrinnovate India, a company owned by the Department of Agricultural, Research & Education, Ministry of Agriculture, it added.

Read also: Alembic Pharma JV bags USFDA nod for Efinaconazole Topical Solution

"Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100 per cent protection," Hester Biosciences said.

The company plans to launch both the vaccines commercially in approximately 8 months, it added.


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News